NIH-funded research NIH-funded research

Non-invasive, automated heart health checker for early heart failure and pulmonary hypertension

Official title: A non-invasive, automated platform for hemodynamic assessment of patients at risk of heart failure or pulmonary hypertension

Funded at Sensydia Corporation · NIH-11322000 · Data updated 2026-11-12

A new non-invasive device platform aims to measure four key heart-hemodynamics (EF, CO, PAP, PCWP) safely at home or in basic clinics to help people at risk of heart failure or pulmonary hypertension.

More Hypertension research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSensydia Corporation
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startMay 5, 2023
Project endMarch 31, 2027
Funding year2026
Award (this year)$816,106
NIH project number5R42HL167342-03
Project IDNIH-11322000 on NIH RePORTER

Who could benefit from this research

Could help

Adults 21 years and older who are at risk for heart failure or pulmonary hypertension.

Less likely to help

Patients without heart conditions or those not needing hemodynamic monitoring may not benefit.

What this research studies

This project offers an automated, non-invasive tool that can estimate important heart health metrics without the need for risky catheterization or specialized staff. It seeks to provide results comparable to invasive methods, potentially enabling earlier diagnosis and ongoing monitoring for people with or at risk of heart failure or pulmonary hypertension. The device is designed to be easy to use, potentially expanding access to key diagnostics beyond high-resource centers. Patients may benefit from safer, more affordable testing and closer surveillance of their heart condition as it progresses or responds to treatment.

Why it matters

Potential benefit: If successful, patients could receive safer, cheaper, and more accessible heart health assessments with timely guidance for treatment decisions.

How similar studies have gone: Previous methods rely on invasive catheterization or specialized imaging; this work seeks a non-invasive alternative with comparable accuracy.

Where this research is happening

  • Sensydia Corporation
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Mahajan, Aman — Sensydia Corporation
  • Study coordinator: Mahajan, Aman

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.